This research demonstrates potent antiproliferative activity in cancer cell lines using novel selenocyanate derivatives, suggesting therapeutic potential.
Key Points
Compound 6h showed significant inhibitory effects against SKOV‐3 cells with an IC50 of 1.96 μM, indicating high potency.
The synthesized selenophenol selenocyanates were structurally confirmed through techniques like 1H/13C NMR and HR-MS, ensuring their validity.
Antiproliferation activities were assessed using MTT assay, confirming the effectiveness of these compounds against various cancer lines.
The novel derivatives may serve as a promising class of selenium-based therapeutics, highlighting their potential for medicinal applications.